Arkolith/Insider Trading/EMMA/Form 4

Niihara Yutaka

Chairman and CEO, Director, 10% OwnerEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Feb 9, 2022
Net Buying
Open-Market Buys
$13K
Open-Market Sells
$0
Net Open-Market Flow
$13K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 8, 2022Buy(P)3K$1.49$5K11.2M
Feb 7, 2022Buy(P)5K$1.47$8K11.2M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-007990) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML